Cryo-Cell International (FRA:ZCY) Total Assets : €60.93 Mil (As of Nov. 2024)

View and export this data going back to 1990. Start your Free Trial

What is Cryo-Cell International Total Assets?

Cryo-Cell International's Total Assets for the quarter that ended in Nov. 2024 was €60.93 Mil.

During the past 12 months, Cryo-Cell International's average Total Assets Growth Rate was 1.60% per year. During the past 3 years, the average Total Assets Growth Rate was 5.40% per year. During the past 5 years, the average Total Assets Growth Rate was 13.70% per year. During the past 10 years, the average Total Assets Growth Rate was 23.30% per year.

During the past 13 years, Cryo-Cell International's highest 3-Year average Total Assets Growth Rate was 53.60%. The lowest was -17.80%. And the median was 14.45%.

Total Assets is connected with ROA %. Cryo-Cell International's annualized ROA % for the quarter that ended in Nov. 2024 was -11.89%. Total Assets is also linked to Revenue through Asset Turnover. Cryo-Cell International's Asset Turnover for the quarter that ended in Nov. 2024 was 0.13.

Cryo-Cell International Total Assets Historical Data

The historical data trend for Cryo-Cell International's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cryo-Cell International Total Assets Chart

Cryo-Cell International Annual Data

Trend

Nov15

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

Nov22

Nov23

Nov24

Total Assets

Get a 7-Day Free Trial

39.09

53.14

63.66

56.57

60.93

Cryo-Cell International Quarterly Data
	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24
Total Assets	Get a 7-Day Free Trial															56.57	57.21	57.87	57.08	60.93

Cryo-Cell International Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Cryo-Cell International's Total Assets for the fiscal year that ended in Nov. 2024 is calculated as

Total Assets	=	Total Equity (A: Nov. 2024 )	+	Total Liabilities (A: Nov. 2024 )
	=	-12.449	+	73.376
	=	60.93

Cryo-Cell International's Total Assets for the quarter that ended in Nov. 2024 is calculated as

Total Assets	=	Total Equity (Q: Nov. 2024 )	+	Total Liabilities (Q: Nov. 2024 )
	=	-12.449	+	73.376
	=	60.93

Cryo-Cell International (FRA:ZCY) Total Assets Explanation

Total Assets is connected with ROA %.

Cryo-Cell International's annualized ROA % for the quarter that ended in Nov. 2024 is

ROA %	=	Net Income (Q: Nov. 2024 )	/	( (Total Assets (Q: Aug. 2024 )	+	Total Assets (Q: Nov. 2024 ))	/ count )
	=	-7.016	/	( (57.081	+	60.927)	/ 2 )
	=	-7.016	/	59.004
	=	-11.89 %

Note: The Net Income data used here is four times the quarterly (Nov. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Cryo-Cell International's Asset Turnover for the quarter that ended in Nov. 2024 is

	Asset Turnover
=	Revenue (Q: Nov. 2024 )	/	( (Total Assets (Q: Aug. 2024 )	+	Total Assets (Q: Nov. 2024 ))	/ count )
=	7.559	/	( (57.081	+	60.927)	/ 2 )
=	7.559	/	59.004
=	0.13

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Cryo-Cell International Total Assets Related Terms

Thank you for viewing the detailed overview of Cryo-Cell International's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Cryo-Cell International Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cryo-Cell International Inc (FRA:ZCY) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

CCEL:USA ZCY:Germany

Address

700 Brooker Creek Boulevard, Suite 1800, Oldsmar, FL, USA, 34677

Website

https://www.cryo-cell.com

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.

Cryo-Cell International Headlines

No Headlines